BASALOG 100IU/ML (Insulin Glargine (100IU/ml))

Basalog 100IU/ml Injection is a long-duration insulin formulation designed to assist in managing both type 1 and type 2 diabetes in individuals of all ages, including children. It helps maintain a consistent insulin level throughout the day, thus aiding in the regulation of blood sugar concentrations and minimizing the risks associated with diabetes. This medication can be utilized on its own or alongside rapid-acting insulins or other antidiabetic drugs. Proper instruction from a healthcare professional regarding subcutaneous injection techniques is essential. Adherence to the prescribed dosage is crucial for achieving optimal therapeutic benefits. Discontinuation of the medication could lead to markedly elevated blood sugar levels, increasing the likelihood of severe health complications. It is important to recognize that this medication is part of a broader diabetes management strategy that should also encompass a nutritious diet, physical activity, and, if necessary, weight management, as recommended by a healthcare provider. The primary adverse effect linked to Basalog 100IU/ml Injection is hypoglycemia, or low blood sugar levels. To mitigate this risk, it is imperative to administer only the advised dosage, maintain regular meal times, and frequently monitor blood glucose levels. Excessive alcohol intake may further exacerbate the risk of hypoglycemia. Additional side effects may include swelling in the extremities, changes in fat distribution, allergic responses, reactions at the injection site, skin irritations, and potential weight gain.